This is very exciting for people like me, who have spent 20 to 30 years taking care of patients with this condition, said Arun Sanyal, M.D., director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health
The results also showed that participants were less willing to associate with the individual who regained weight after stopping medication compared to the person who maintained weight loss
Shima Hadidchi, MDs practice, we are dedicated to providing safe, effective, and personalized weight management solutions for every patient
The MHRA has warned that very rarely people taking semaglutide (the ingredient in Wegovy) can have a sudden deterioration in their eyesight, leading to full or partial loss of vision, usually in one eye at a time
GLP-1 Receptor Agonists and the Path to Sustainable Obesity Care
Generally, Ozempic is more likely to be covered by insurance plans when prescribed for its FDA-approved indication of type 2 diabetes